|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/6886 |
| (11) | Patento numeris | 2981624 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14779403.6 |
| Europos patento paraiškos padavimo data | 2014-04-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-02-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-12-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/033014 |
| Data | 2014-04-04 |
| (87) | Numeris | WO 2014/165785 |
| Data | 2014-10-09 |
| (30) | Numeris | Data | Šalis |
| 201361809105 P | 2013-04-05 | US | |
| 201361913762 P | 2013-12-09 | US |
| (72) |
ABKEVICH, Victor, US
TIMMS, Kirsten, US
GUTIN, Alexander, US
|
| (73) |
Myriad Genetics, Inc.,
320 Wakara Way, Salt Lake City, UT 84108,
US
|
| (54) | METHODS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY AND PREDICTING RESPONSE TO CANCER TREATMENT |
| METHODS FOR ASSESSING HOMOLOGOUS RECOMBINATION DEFICIENCY AND PREDICTING RESPONSE TO CANCER TREATMENT |